National Institutes of Health publishes research involving Blessing Health Hannibal doctor

HANNIBAL, Mo. — Dr. Humam Farah of Blessing Health Hannibal participated in a complex COVID-19 research study. Results of that study were recently published by the National Institutes of Health.

Farah also has been recognized globally for his research work on the condition known as Alpha-1, also called AAT Deficiency. The condition results in a shortage of AAT, a protein that protects the lungs and liver from damage. The deficiency can lead to chronic obstructive pulmonary disease, liver disease and can be fatal.

Farah is the director of the Pulmonology, Research, Sleep Disorder Center and Alpha-1 Center at Blessing Health Hannibal and a 12-year member of the Blessing Health Hannibal provider team. Farah is triple board certified by the American Boards of Pulmonary Disease, Critical Care and Sleep. A fellowship was completed at the University of Illinois Chicago and a residency at St. Louis University Hospital.